Skip to main content
. 2014 Jun 9;18(11):2165–2175. doi: 10.1111/jcmm.12326

Figure 9.

Figure 9

NAADP-lysosome Ca2+-controlled high glucose–induced dynein activation. (A) Summarized data showing the effects of Nox1 inhibitor ML117 (100 μM) on O2 production in CAMs under control and high glucose (30 mM) for 48 hrs. Summarized data showing the effects of Nox1 inhibitor ML117, dynein inhibitor EHNA and NAADP antagonists PPADS or NED-19 on dynein ATPase activity (B) or APLs formation (red-to-green fluorescence ratio of acridine orange; C) in CAMs under resting control condition or with high glucose (n = 6 for all panels). *P < 0.05 versus Ctrl; #P < 0.05 versus CAMs treated with high glucose.